MindMed news

Insight and news from the team

News posts

Video

FOX BUSINESS – Psychedelics may have potential therapeutic benefits

MindMed Co-CEO on taking the company public

MindMed co-CEO JR Rahn: Psychedelics as medicine in opioid addiction and ADHD

Psychedelic Research Company MindMed Kicks Off Trading on NEO Exchange

Kevin O'Leary talks MindMed and why he's invested in psychedelics